Stanford Kimberly A, Mason Joseph A, Friedman Eleanor E
Department of Medicine, Section of Emergency Medicine, University of Chicago, Chicago, IL, United States.
Department of Medicine, Section of Infectious Diseases and Global Health, University of Chicago, Chicago, IL, United States.
Front Reprod Health. 2023 Feb 20;5:1082429. doi: 10.3389/frph.2023.1082429. eCollection 2023.
The COVID-19 pandemic has had profound effects on access to care, including outpatient sexually transmitted infection (STI) testing and treatment. Many vulnerable populations already relied on the emergency department (ED) for much of their care prior to the pandemic. This study examines trends in STI testing and positivity before and during the pandemic at a large urban medical center and evaluates the role of the ED in providing STI care.
This is a retrospective review of all gonorrhea, chlamydia, and trichomonas tests from November 1, 2018, through July 31, 2021. Demographic information and location and results of STI testing were extracted from the electronic medical record. Trends in STI testing and positivity were examined for 16 month periods before and after the COVID-19 pandemic started (March 15, 2020), with the latter divided into the early pandemic period (EPP: March 15 -July 31, 2020) and late pandemic period (LPP: August 1, 2020 - July 31, 2021).
Tests per month decreased by 42.4% during the EPP, but rebounded by July 2020. During the EPP, the proportion of all STI testing originating in the ED increased from 21.4% pre-pandemic to 29.3%, and among pregnant women from 45.2% to 51.5%. Overall STI positivity rate increased from 4.4% pre-pandemic to 6.2% in the EPP. Parallel trends were observed for gonorrhea and chlamydia individually. The ED represented 50.5% of overall positive tests, and as much as 63.1% of positive testing during the EPP. The ED was the source of 73.4% of positive tests among pregnant women, which increased to 82.1% during the EPP.
STI trends from this large urban medical center paralleled national trends, with an early decrease in positive cases followed by a rebound by the end of May 2020. The ED represented an important source of testing for all patients, and especially for pregnant patients, throughout the study period, but even more so early in the pandemic. This suggests that more resources should be directed towards STI testing, education, and prevention in the ED, as well as to support linkage to outpatient primary and obstetric care during the ED visit.
新冠疫情对医疗服务的可及性产生了深远影响,包括门诊性传播感染(STI)检测与治疗。在疫情之前,许多弱势群体的大部分医疗服务依赖于急诊科(ED)。本研究调查了一家大型城市医疗中心在疫情之前及期间的性传播感染检测及阳性率趋势,并评估了急诊科在提供性传播感染护理方面的作用。
这是一项对2018年11月1日至2021年7月31日期间所有淋病、衣原体和滴虫检测的回顾性研究。从电子病历中提取人口统计学信息、性传播感染检测的地点及结果。对新冠疫情开始前(2020年3月15日)和开始后16个月期间的性传播感染检测及阳性率趋势进行了研究,后者分为疫情早期(EPP:2020年3月15日至7月31日)和疫情后期(LPP:2020年8月1日至2021年7月31日)。
在疫情早期,每月检测量下降了42.4%,但到2020年7月有所反弹。在疫情早期,所有性传播感染检测中源自急诊科的比例从疫情前的21.4%增至29.3%,孕妇中的这一比例从45.2%增至51.5%。总体性传播感染阳性率从疫情前的4.4%增至疫情早期的6.2%。淋病和衣原体各自呈现出类似趋势。急诊科的阳性检测占总体阳性检测的50.5%,在疫情早期高达63.1%。急诊科是孕妇阳性检测的73.4%的来源,在疫情早期增至82.1%。
这家大型城市医疗中心的性传播感染趋势与全国趋势相似,阳性病例早期减少,到2020年5月底出现反弹。在整个研究期间,急诊科是所有患者检测的重要来源,尤其是孕妇,但在疫情早期更是如此。这表明应将更多资源用于急诊科的性传播感染检测、教育和预防,以及在急诊科就诊期间支持与门诊初级和产科护理的衔接。